Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 27, 2012

View Archived Issues

New data support Tmprss6 as a therapeutic target for beta-thalassemia and hereditary hemochromatosis

U.S. researchers design novel heterodimeric targeting ligands

Ironwood Pharmaceuticals begins phase I trial of antianxiety drug candidate

Halozyme Therapeutics and Pfizer to develop recombinant human hyaluronidase biologics

Phase II TO-2061 trial in OCD does not meet primary endpoint

A new vaccine target identified for the treatment of parasitic Schistosomiasis

Novel alpha7 nAChR receptor agonist designed by Siena Biotech and Pfizer

Endo returns global rights for Urocidin

Novel diagnostic agents for AD patented by Nihon Medi-Physics

Catabasis Pharmaceuticals presents new GABA conjugates

Spectrum Pharmaceuticals' pivotal BELIEF trial meets primary endpoint

Novel agents for obesity disclosed by GlaxoSmithKline

Researchers at Merck & Co. patent new PDE10A inhibitors

Ranbaxy Laboratories presents new DPP IV inhibitor for the treatment of diabetes

The Wistar Institute divulges new EBNA-1 protein inhibitors

Two novel mutations identified in patient with cyclic neutropenia

Raptor Pharmaceutical provides update on NDA review for Procysbi

Recommendations presented by AAC on Ampligen for chronic fatigue syndrome

U.K. regulators set to approve Horizon Pharma's MAA for Duexis

Only For Children Pharmaceuticals withdraws MAA for Loulla

Cubist submits supplemental NDA to FDA for Entereg

FDA approves Juxtapid for homozygous familial hypercholesterolemia

A dual SYK/JAK inhibitor shows potential in animal models of arthritis and B-cell malignancies

Acorda Therapeutics completes acquisition of Neuronex

Sarepta Therapeutics enters into influenza trial agreement with the NIAID

Once-monthly formulation of antiosteoporotic agent approved in Japan

Results published from phase II trial of immunocytokine therapy in melanoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...